After primary infection, human cytomegalovirus (HCMV) persists as a life-long latent infection, with host immunosuppression often resulting in clinical reactivation. During lytic infection, major changes in the expression of secreted cellular proteins (the secretome) occur that have profound effects on host-cell interactions, particularly at the level of the host immune response. In contrast, little is known about changes in the secretome that accompany latent infection, yet this is likely to be of major importance for the life-long carriage of this persistent human pathogen in the face of constant immunosurveillance. We have analyzed the secretome of cells carrying latent HCMV and have identified changes in several secreted cellular proteins known to be involved in regulation of the immune response and chemoattraction. Here, we show that a latency-associated increase in CC chemokine ligand (CCL)8 results in the recruitment of cluster of differentiation (CD)4 + T cells to supernatants from latently infected CD34 + cells but that these latent supernatants, also rich in immunosuppressive factors, inhibit cytokine secretion and cytotoxicity of HCMV-specific T-helper (Th)1 CD4 + T cells. These results identify a strategy by which sites of latent HCMV can firstly recruit CD4 + T cells and then inhibit their antiviral effector functions, thereby aiding the maintenance of latent infection in the face of the host immune response.
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herpesvirus | immune evasion P rimary human cytomegalovirus (HCMV) infection of the immunocompetent rarely causes disease. However, infection in individuals whose immune systems are compromised or immature (such as HIV/AIDS patients, transplant patients, or the fetus in utero) can be life-threatening. Indeed, in the settings of congenital infection, it is the most common infective cause of congenital damage to the central nervous system, and it is a major cause of morbidity and mortality in the context of organ and bone marrow allografting and advanced HIV infection.
Unlike many other viruses, HCMV is never cleared after primary infection but persists for the lifetime of the host. In part, this is attributable to the profound ability of HCMV to avoid immunosurveillance during its lytic cycle by expression of virally encoded immunoavoidance genes. However, lifelong viral persistence is also underpinned by a biological property of all herpesviruses: the ability to undergo latent infection.
During latency, characterized by a lack of production of infectious virus, viral genomes are carried in cells where viral lytic transcription is suppressed, and only a subset of viral genes are expressed (1) (2) (3) (4) (5) . It is now clear that reactivation of virus from these latent pools is also a major cause of the HCMV-mediated disease observed in the immunocompromised/immunonaïve setting.
Similarly, subclinical HCMV infection may be associated with long-term diseases such as atherosclerosis, chronic graft rejection, and neoplasias, in which reactivation is likely to be a major source of virus (6) . Consequently, viral latency is an important part of the viral lifecycle, but has been relatively neglected to date and yet underpins the pathogenesis of this important human pathogen.
HCMV is known to regulate the secretion of numerous cellular chemokines, cytokines, and growth factors during lytic infection (7, 8) . Little is known, however, about the changes that occur in the secretome during latent infection, and yet this is likely to be of great importance for carriage of latently infected cells in vivo.
Myeloid cells are a site of HCMV latency in vivo, and there is a critical linkage between their terminal differentiation to dendritic cells (DCs) and transcriptional reactivation of latent virus (9) . In vivo, 0.001-0.01% of myeloid progenitor cells carry latent virus (10) , and there is no natural animal model for HCMV. Consequently, many aspects of HCMV latency have been studied in experimental latent myeloid models.
During experimental latent infection of granulocyte-macrophage progenitor cells (GMPs), CC chemokine ligand (CCL)2 [monocyte chemoattractant protein (MCP-1)] is up-regulated, and this enhances chemotaxis of cluster of differentiation (CD) 14 + monocytes (11) . However, whether changes in secretion of other cytokines accompanies latent HCMV infection and what effect this has on chemotaxis and function of other immune cells, such as T cells and NK cells, which are known to play important roles in immunosurveillance of HCMV, is not known.
Consequently, we have used an established experimental model of HCMV latency in CD34 + progenitor cells (12) to study the changes that HCMV causes in the CD34 + cell secretome. Our data show that latent infection with HCMV causes major changes in secretion of specific cellular cytokines and chemokines, which results in CD4 + T-cell chemotaxis. Furthermore, these supernatants suppress the production of the T-helper (Th)1 cytokines IFN-γ, TNF-α, and TNF-β, as well as inhibiting HCMVspecific MHC II-restricted cytotoxicity. These data suggest the microenvironment around cells latently infected with HCMV is highly immunosuppressive and highlights a mechanism by which HCMV avoids immune responses during latent infection.
We initially screened supernatants of CD34 + progenitor cells latently infected with a clinical strain of HCMV, Merlin, to identify latency-specific changes in the cell secretome using antibody arrays. To control for changes resulting from virus binding, which can, in itself, lead to profound changes in cellular gene expression (13, 14) , we also analyzed CD34 + cells infected with UV-inactivated Merlin. A representative screen is presented in Fig. S1 Aa-Ad, where all data are fold changes in proteins secreted by CD34 + cells latently infected over levels observed for CD34 + cells infected with UV-inactivated virus. This analysis showed a number of changes in the latency-associated secretome (Fig. S1A ) that included robust up-regulation of chemokines. The management of immune cell migration to a site of latent infection might have obvious advantages, but also possible disadvantages, for the latently infected cell. Consequently, we validated the up-regulation of CCL8 and CCL2, which we had observed in our original screen by ELISA (Fig.  1A) . Interestingly, the observed increase in CCL8 during latent infection of CD34 + cells was routinely higher than that observed for CCL2 by both clinical virus isolates used (Fig. 1A and Fig.  S1A and see Fig. S3A ). We observed no significant migration of NK, B, or CD8 + T cells that could be attributed to latent infection of CD34 + cells across the eight donors analyzed, regardless of their HCMV serostatus. In contrast, and consistent with previously published observations (11), we did observe recruitment of CD14 + monocytes to latent supernatants, and this was consistently observed in all eight donors, again regardless of serostatus.
However, by far the most robust effect we observed was on recruitment of CD4 + T cells to the supernatants of latently infected CD34 + cells (Fig. 1B and Fig. S2 A-E). This recruitment of CD4 + T cells to latent supernatants was observed independently in four HCMV-seropositive and four seronegative donors, arguing that recruitment, as for CD14 + monocytes, was independent of donor HCMV serostatus. Similarly, we ensured that all individual isolated subpopulations retained their ability to migrate in the transwell assay to positive control supernatants from LPS-stimulated monocyte-derived macrophages ( Fig. S2 A-E).
CCL8 Induces Chemotaxis of CC Chemokine Receptor (CCR)3-and CCR5-Expressing CD4 + T Cells. Both CCL2 and CCL8, which were substantially increased in supernatants from latently infected CD34 + cells (Fig. 1A and Fig. S1A ), are known ligands of CCR2. However, CCL8 is also a ligand of CCR3 and CCR5 (15) . To identify whether these receptors were involved in the observed recruitment of CD4 + T cell to latent supernatants, we determined the level of their expression on CD3 + CD4 + T cells. We analyzed CD3 + CD4 + T cells from four HCMV-seropositive and four seronegative donors for their levels of expression of CCR1, CCR2, CCR3, and CCR5. Fig. 2A shows that, in contrast to CD8 + T cells (CD4 − CD3 + ), which had a low frequency of expression of CCR1, CCR2, CCR3, or CCR5 receptors, a higher frequency of CD3 + CD4 + T cells expressed significant levels of both CCR3 and CCR5. This was observed for all eight donors examined, regardless of HCMV serostatus (CD4 + CCR3 + : 0.6-1.1%; CD4 + CCR5 + : 1.0-1.7%). Furthermore, we costained for CCR3 and CCR5 to determine whether CCR3 and CCR5 are coexpressed on these CD3 + CD4
+ T cells. Although we observed heterogenous expression of these chemokine receptors on the peripheral blood CD4 + T-cell population, a substantial population of cells expressed both CCR3 and CCR5 (Fig. S2F) .
To assess whether CCR3 and CCR5 were the key receptors involved in mediating the increased CD4 + T-cell migration to latent supernatants, we depleted CCR3-and CCR5-bearing CD4 + T cells and assessed their ability to migrate to supernatants from latently infected CD34 + cells. Fig. 2B shows that depletion of CD4 + T cells bearing CCR3 or CCR5, as well as depletion of cells expressing both receptors, abolished CD4 + Tcell migration to latent supernatants. These cells still retained their ability to migrate to supernatants from LPS-stimulated monocyte-derived macrophages (Fig. S2G) .
Because CCL8 was substantially increased in supernatants of latently infected cells and CCL8 is a potential ligand for both CCR3 and CCR5 ( Fig. 1A and Fig. S1Aa ), we tested whether neutralizing CCL8 in the supernatants from latently infected CD34 + cells with specific antibody would prevent CD4 + T-cell migration; this clearly resulted in a significantly reduced CD4 + T-cell migration to supernatants from latently infected CD34 + cells (Fig. 2C) . Thus, the chemoattraction of CD4 + T cells to supernatants from latently infected CD34 + cells is attributable to the induced levels of CCL8 in a CCR3-/5-dependent manner.
Latency-Induced Secretome Inhibits Th1 Cytokine Production. The production of CCL8 and recruitment of CD4 + T cells by the latent secretome was a surprising observation. However, our secretome analysis showed that cellular (c)IL-10 was also robustly induced by latent infection of CD34 + cells (Fig. S1Ac ). cIL-10 is a known suppressive cytokine and plays a crucial role in peripheral tolerance by suppressing T-cell proliferation and effector function (16) . Cells which migrated to the supernatants were visualized by microscopy using five separate fields of view per well and enumerated using ImageJ software. Error bars represent SEM from the eight independent donors and statistics were performed using the Student's t test.
We also noted a smaller but reproducible increase in the secretion of TGF-β by latently infected cells (Fig. S1Ad) . As a pluripotent growth factor, TGF-β not only regulates cell proliferation (17, 18) but also has profound inhibitory effects on the immune system (19) (20) (21) .
To confirm the robustness of these observations, we reanalyzed supernatants from CD34 + cells latently infected with a different clinical isolate of HCMV. We observed similar increases in both cIL-10 and TGF-β, as well as CCL2 and CCL8, in independent analyses using the TB40E strain of HCMV (Fig. S3A) . Furthermore, an analysis of the changes in the production of cIL-10 and TGF-β over a time course of 3, 6, and 9 d of latent infection (Fig.  S3 B and C) showed that these changes were not observed at 3 d postinfection, arguing that they did not result from transient short-term changes attributable to infection per se.
The robust increase in latency-induced secretion of the immunomodulatory cytokines cIL-10 and TGF-β by both clinical strains examined led us to ask whether these latency-induced cytokines perturbed production of cytokines normally produced by CD4 + T cells after polyclonal stimulation with phytohemagglutinin (PHA). Fig. 3 A-D clearly shows that, as expected, polyclonal activation of CD4 + T cells resulted in the production of Th1 cytokines (IFN-γ, TNF-α, and TNF-β) (22, 23) and the non-Th1 cytokine IL-6. However, in the presence of supernatant from latently infected CD34 + cells, there was a significant decrease in levels of these Th1-associated cytokines IFN-γ, TNF-α, and TNF-β ( Fig. 3 A-C) but no effect on the production of the non-Th1 cytokine IL-6 by CD4 + T cells (Fig. 3D ). This ruled out a global inhibition of CD4 + T-cell cytokine production by supernatants from latently infected CD34 + cells. To determine whether the inhibition of Th1 cytokines by latent supernatants was attributable specifically to latency-induced cIL-10 and TGF-β (Figs. S1 Ac and Ad and S3 A-C), we reassessed this inhibition in the presence of neutralizing cIL-10 and TGF-β antibodies. Fig. 3E shows that neutralizing either cIL-10 or TGF-β significantly increased IFN-γ production and neutralizing cIL-10 and TGF-β simultaneously had an additive effect upon the restored IFN-γ production.
To assess whether the changes to the CD34 + secretome were maintained during extended periods of experimental latency, we also analyzed the latency-associated secretome after 20 d of latent infection. (The cells were washed, fresh media was replaced 10 d postinfection, and latently infected cells were incubated for a further 10 d.) This day-20 latency-associated secretome was analyzed for CCL8, IL-10, and TGF-β expression, as before. All three cytokines were expressed by latently infected CD34 + cells compared with mock and UV controls after this much extended period of latent infection (Fig. S4A) . We also tested whether this 20 d latency-associated secretome could inhibit CD4 + IFN-γ production, and the results clearly showed inhibition of IFN-γ production by CD4 + T cells Fig. S4B ).
Latency-Induced Secretome Is Able to Inhibit CD4 + T-Cell-Mediated
Cytotoxicity. Cell mediated cytotoxicity is usually associated with CD8 + T cells or NK cells, it is well established with HCMV that some Th1 type CD4 + T cells demonstrate MHC Class II restricted cytotoxicity (24) . Our observations that supernatants from latently infected CD34
+ cells inhibited Th1 cell cytokine production led us to ask whether these supernatants had any effect on CD4 + T-cell cytotoxic function. Using an established model of HCMV glycoprotein (g)B-specific CD4 + T cells (Fig.  S5) , we asked whether supernatants from latently infected CD34 + cells could inhibit CD4 + T-cell-mediated cytotoxicity by reassessing gB-specific killing in the presence of supernatants from mock-, UV virus-, and latently infected CD34 + cells (Fig.  4A) . CD4 + T-cell-mediated cytotoxicity was significantly inhibited by supernatants from latently infected CD34 + cells. We observed similar inhibition of gB-specific cytotoxicity in four separate experiments from four separate donors.
To address whether this inhibition of cytotoxic effector function was attributable to the latency-associated increase in immunomodulatory cytokines, we repeated the analyses in the presence of neutralizing anti-IL-10 and anti-TGF-β antibodies or isotype-matched control antibodies. Fig. 4B shows a complete recovery of cytotoxic effector function upon neutralization of IL-10 and TGF-β in the supernatants from latently infected CD34 + cells.
Intracellular Cytokine Staining Shows That the Latent Secretome
Induces IL-10 and TGF-β Expression in Uninfected Bystander CD34 + Cells. We have shown that supernatants from latently infected CD34 + cells contain elevated levels of both cIL-10 and TGF-β. To determine whether only the latently infected cells are responsible for the production of these cytokines or whether bystander cells in the population culture are also induced to express these cytokines, we analyzed the expression of cIL-10 and TGF-β in uninfected bystander in the latently infected cells population. CD34 + cells were infected with an isolate of HCMV TB40E (TB40GFP), which expresses GFP under the control of the SV40 origin/promoter cassette (25) and allows expression of GFP in infected undifferentiated myeloid cells (26) . Forty-eight hours postinfection, cIL-10 and TGF-β expression was analyzed by intracellular cytokine staining. Fig. S6A shows that virusinfected cells (GFP-positive) express both IL-10 and TGF-β, as expected, with no staining observed using relevant isotypematched control antibodies. Similarly, control CD34 + cells had no detectable IL-10 and TGF-β expression (Fig. S6C) . The relative number of mock-infected, latently infected (GFP + ) or uninfected bystander cells (GFP − ) in the population coexpressing cIL-10 were enumerated by counting 20 fields of view of 100 cells each (Fig. 5) . Consistent with an induction of cIL-10 and TGF-β in uninfected bystander cells during latent infection, some uninfected cells in the population also showed high levels of cIL-10 and TGF-β (Fig. S5A) , and, perhaps more tellingly, supernatants from latently infected cells induced high levels of cIL-10 and TGF-β on the CD34 + cell population, which was not observed with supernatants from mock or UV virus-treated CD34 + cells (Fig. 5 and Fig. S5B ).
Discussion
The latent HCMV-induced modulation of CD34 + cell secretome is likely to be of major importance for the life-long carriage of this persistent human pathogen in the face of a robust immune response. We show that latent infection of CD34 + progenitor cells with HCMV results in major changes in the cell secretome. Some of these changes clearly resulted from binding of virus particles to CD34 + cells because increases are also detected in cell supernatants after infection with UV-inactivated virus. However, many other changes could not be attributable to virus binding because they did not occur after infection with UVinactivated virus, arguing that these resulted from viral gene expression associated with latent infection. Our results also suggest that once the latent secretome is established, it is maintained long term (some 20 d of experimental latent infection), because the increase in TGF-β and cIL-10, which was observed in supernatants from CD34 + cells latent for 6 d, was actively maintained at 9-and 20-d latency (even after replenishment of fresh medium at the time points of harvest) (see Fig. S3 ). Intracellular staining for TGF-β and cIL-10 shows that virus-infected CD34 + cells express these cytokines, but, importantly, uninfected bystander CD34 + cells can be induced to express TGF-β and cIL-10 by the secretome from latently infected cells.
Many of the cytokines that changed during latent infection would likely have profound effects on cell survival, cell proliferation, and migration and could also modify the latently infected cell microenvironment to manipulate immune regulation. Fig. 3 . Latency-associated secretome inhibits the production of the Th1-associated cytokines IFN-γ, TNF-α, and TNF-β. CD4 + T cells were purified and resuspended in X vivo media (white bars), and supernatants from CD34 + cells were mock-infected (gray bars) or latently infected with the TB40E strain of HCMV (black bars). CD4 + T cells were then incubated either unstimulated or stimulated using PHA. After 18 h, supernatants were removed, and levels of IFN-γ(A), TNF-α(B), TNF-β (C), and IL-6 (D) were determined by flow cytometric methods. Data are representative of three independent experiments, error bars represent three replicates per experiment, and statistical analysis was performed using the Student's t test. (E) Supernatants from CD34 + cells latently infected by the TB40E strain of HCMV were incubated with anti-IL-10, anti-TGF-β or the relevant isotype control antibodies before CD4 + T cells were added and stimulated with PHA. After 18 h the concentration of IFN-γ was determined by flow cytometric methods. Representative data of three independent experiments, error bars represent three replicates per experiment and statistical analysis was performed using the Student's t test. + cells infected latently with the TB40E strain of HCMV or with a UVinactivated virus were again used to preincubate gB-specific CD4 + T cells before a standard chromium-release assay with the addition of anti-TGF-β and anti-IL-10 antibodies (black bars) or isotype-matched control antibodies (white bars) before the addition of the T cells. Data are representative of four independent experiments, error bars represent SEM from five replicates, and statistical analysis was performed using the Student's t test.
We have chosen to focus this study on the effects on CD4 + and CD8 + T-cell, NK-cell, and B-cell migration, as well as assessing the supernatants for immunomodulatory activity.
Supernatants from latently infected cells contain high levels of the chemokine CCL8, which induces chemotaxis of CD4 + T cells. This observation is counterintuitive: why would a site of latency, important for the lifelong persistence of HCMV, induce recruitment of CD4 + T cells and, as such, increase the opportunity to be subject to CD4 + T-cell surveillance? CCL8 secretion may be beneficial to latently infected cells in a way that is presently unclear. Alternatively, it may be a cellular response to latent infection that the virus is unable to prevent but is offset by other components of the latency associated secretome.
Consistent with this, the latent secretome also contained high levels of the immunosuppressive cytokines TGF-β and cIL-10, which specifically modulate the effector function of Th1 CD4 + T cells, resulting in inhibition of inflammatory cytokine production (IFN-γ, TNF-α, and TNF-β) and MHC class II-restricted cytotoxicity. The frequency of CD34 + cells carrying latent virus is very low [0.01-0.001% (10)]; however, our results suggest that the altered secretome induced by latent virus can affect bystander uninfected CD34 + cells, inducing them to express TGF-β and cIL-10 and, thus, creating an immunosuppressive microenvironment around latently infected CD34 + cells. Our observations are consistent with other work that has shown that the viral (v)IL-10 induces an immunosuppressive phenotype in uninfected monocytes, which includes the induction of TNF-β (27) .
Our results are consistent with the known properties of TGF-β, which is a pleiotropic immunomodulatory cytokine. TGF-β decreases tyrosine phosphorylation of both Signal Transducer and Activation of Transcription (STAT)3 and STAT4, as well as regulating the TGF-β/Smad pathway via transcription factors similar to mother against decapentaplegic (Smad) and activating transcription factor (ATF)1, thus resulting in a reduction of IFN-γ production (28, 29) . TGF-β has also been shown to inhibit Tcell cytotoxicity directly by blocking the expression of four components of the cytotoxicity pathway: perforin, granzyme A, granzyme B, and Fas ligand. Inhibition of these cytolytic mediators effects both granule exocytosis and contact-dependent mechanisms of cytotoxicity, and, consistent with our own observations, this can be reversed by the addition of neutralizing TGF-β antibody (30) .
cIL-10 also has a well-established immunosuppressive effect on the T-cell response. cIL-10 significantly reduces CD4 + T-cell proliferation and Th1 cytokine secretion either by polyclonal PHA stimulation or by specific antigen stimulation (31) (32) (33) , again consistent with our findings that neutralizing cIL-10 antibody reversed this effect of the CD34 + latent secretome. It is also notable that the combination of neutralizing TGF-β and cIL-10 had an additive effect in our experiments. It is interesting to note that HCMV also encodes an IL-10 homolog (cmvIL-10), which shares some of the immunosuppressive functions of cIL-10 in that it can regulate MHC II levels and restrict CD4 + T-cell activation (34, 35) . During latency, a spliced variant of cmvIL-10 is also expressed with some, but not all functions, of the lytically expressed cmvIL-10 variant (35) . However, the cIL-10-neutralizing antibody used in our studies does not cross-react with cmvIL-10 (36), which suggests that the effects we have observed here result specifically from functions of cIL-10 and imply distinct roles for cIL-10 induced by latent infection and virally expressed cmvIL-10.
Taken together, our data suggest that an orchestrated set of strategies are used by HCMV during latent infection of CD34 + cells, which manipulate the microenvironment to enable the latent virus to evade the immune system of the host.
Materials and Methods
Cells and Viruses. CD34 + hematopoietic progenitor cells from the peripheral blood of granulocyte colony-stimulating factor (G-CSF)-mobilized donors were resuscitated as described by the manufacturer (Lonza) and maintained in X-vivo 15 (Lonza) in the absence of serum or growth factors. A low passage isolate of the HCMV Merlin or TB40E strain (37) was used for all infections. TB40E-GFP was a kind gift of Eain Murphy (The Lerner Research Institute, Cleveland, OH) and expresses GFP under the control of the SV40 origin/promoter cassette.
HCMV Latency and Infection. Experimental latent infection of CD34 + cells was established as described previously (12, 36, 38) . For validation of latency, RNA was isolated from CD34 + cells using TRIzol (Invitrogen) and RT-PCRs were performed for Immediate Early (IE), gene 138 of the Unique Long viral genome region (UL138), and GAPDH for 20 cycles of amplification using previously published conditions (36) .
Cytokine and Chemokine Array. CD34 + cells were mock-or latently infected with HCMV for 3 d, the media was changed, and cells were left for a further 7 d before harvesting the supernatants (unless otherwise stated). For timecourse analyses of cIL-10 and TGF-β, CD34 + cells were latently infected with HCMV or UV-inactivated HCMV for 3 d, whereupon media was harvested and fresh media replaced at days 3, 6, 9, and 20. In all cases, cells were infected at a predicted multiplicity of infection (MOI) of 5 (on fibroblasts), leading to ∼40-50% infected cells (36) . Supernatants were cleared by centrifugation and assayed using the RayBio Human Cytokine Antibody Array C Series (100 Combination of Array VI and VII; R&D Systems). Resulting autoradiographic films were analyzed by densitometry using Image J software.
ELISAs. Initially, for CCL8, ELISA supernatants were concentrated fivefold using a 3K Centricon concentrator (Millipore) and then quantified using the RayBiotech kit. For TGF-β and IL-10, supernatants were assayed directly using the Quantikine kit (R&D Systems).
Preparation of Peripheral Blood Mononuclear Cells and Isolation of T Cells, B Cells, Monocytes, and NK Cells. Fresh venous blood was diluted 1:2 with RPMI 1640 (PAA), and peripheral blood mononuclear cells (PBMCs) isolated by Ficoll-Hypaque density gradient centrifugation (Axis-Shield) as described previously (39) . PBMCs were washed twice in PBS and resuspended in RPMI 1640 supplemented 100,000 IU/mL penicillin, 100 mg/mL streptomycin, 2 mmol/mL L-glutamine, and 10% (vol/vol) FCS (RPMI-10). PBMCs were sorted into cellular subpopulations by negative selection using MACS and LS columns (Miltenyi). cells per well. Cultures were maintained at 37°C and 5% CO 2 for 14 d, and a further 50 μL of autologous media was added to each well on days 5 and 10 of culture.
Chromium-Release Cytotoxicity Assays. HCMV gB-specific CD4 + T cells were used in a standard Cr
51
-release assay against HLA-matched and non-HLAmatched B-cell lines as target cells. Before the cytotoxicity assay, gB-specific T cells were resuspended in a range of dilutions of supernatants from mock-, UV-, and latently infected CD34 + cells and incubated overnight. Chromiumrelease cytotoxicity assays were performed as described previously (40) .
Transwell-Migration and CCL8-Neutralization Assay. Cell migration to supernatants was determined using transwell plates (5-μm pore size and 30-μL well volume) (Neuroprobe). Cells were fluorescently labeled using calcein (BD) according to the instructions of the manufacturers. A total of 2.0 × 10 4 labeled cells in 20 μL of RPMI 1640 per well was transferred to the transwell plate and incubated at 37°C for 2 h with supernatants from mock, UV, and latently infected CD34 + cells. As a positive control, supernatants from monocyte-derived macrophages stimulated with LPS were used. Migrated cells were enumerated using an invert UV microscope, the sum of five fields of cells were counted from each well, and assays were performed in triplicate. CCL8 neutralization assays were performed using supernatants or recombinant protein (RayBiotech) preincubated for 1 h with neutralizing anti-CCL8 antibody (R&D Systems; antibody AB-281-NA) or isotype control using the recommended neutralization procedure and dose of the manufacturer (R&D Systems).
Multianalyte Cytokine Assay. Purified CD4 + T cells were resuspended in X-vivo 15 media (Lonza) or supernatants from mock-or latently infected CD34 + cells. These were then either stimulated with PHA (2.5 μg/mL) or unstimulated and plated at 5 × 10 5 CD4 + T cells per well of a 96-well plate and incubated at 37°C and 5% CO 2 overnight. After this time, 100 μL of supernatant was analyzed for cytokine content by multianalyte cytokine bead assay (Bender Med Systems).
Neutralization of IL-10 and TGF-β. Supernatants from mock-, UV-, and latently infected CD34 + cells were treated with neutralizing anti-IL-10 and anti-TGF-β or isotype-matched control antibodies added at a final concentration of 20 ng/mL for 1 h at room temperature before the incubation of the CD4 + T cells.
